138 related articles for article (PubMed ID: 802977)
1. Speech changes in Parkinson's disease during treatment with L-dopa.
Wolfe VI; Garvin JS; Bacon M; Waldrop W
J Commun Disord; 1975 Sep; 8(3):271-9. PubMed ID: 802977
[TBL] [Abstract][Full Text] [Related]
2. Levodopa-induced alterations in speech rate in advanced Parkinson's disease.
De Letter M; Santens P; De Bodt M; Boon P; Van Borsel J
Acta Neurol Belg; 2006 Mar; 106(1):19-22. PubMed ID: 16776432
[TBL] [Abstract][Full Text] [Related]
3. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
Pawlukowska W; Gołąb-Janowska M; Safranow K; Rotter I; Amernik K; Honczarenko K; Nowacki P
Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
[TBL] [Abstract][Full Text] [Related]
4. Effects of Levodopa on Vowel Articulation in Patients with Parkinson's Disease.
Okada Y; Murata M; Toda T
Kobe J Med Sci; 2015 Apr; 61(5):E144-54. PubMed ID: 27363398
[TBL] [Abstract][Full Text] [Related]
5. Prosody and levodopa in Parkinson's disease.
Azevedo LL; Reis CA; Souza IS; Cardoso FE
Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
[TBL] [Abstract][Full Text] [Related]
6. For better or worse: The effect of levodopa on speech in Parkinson's disease.
Ho AK; Bradshaw JL; Iansek R
Mov Disord; 2008 Mar; 23(4):574-80. PubMed ID: 18163453
[TBL] [Abstract][Full Text] [Related]
7. Effect of L-dopa on visual evoked potential in patients with Parkinson's disease.
Bhaskar PA; Vanchilingam S; Bhaskar EA; Devaprabhu A; Ganesan RA
Neurology; 1986 Aug; 36(8):1119-21. PubMed ID: 3736880
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders?
Cantiniaux S; Vaugoyeau M; Robert D; Horrelou-Pitek C; Mancini J; Witjas T; Azulay JP
J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):177-84. PubMed ID: 19793764
[TBL] [Abstract][Full Text] [Related]
9. Acoustic analysis of parkinsonian speech I: speech characteristics and L-Dopa therapy.
Goberman AM; Coelho C
NeuroRehabilitation; 2002; 17(3):237-46. PubMed ID: 12237505
[TBL] [Abstract][Full Text] [Related]
10. Prosodic expression and levodopa in Parkinson's disease.
Behlau M
Arq Neuropsiquiatr; 2013 Nov; 71(11):831-2. PubMed ID: 24394865
[No Abstract] [Full Text] [Related]
11. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
[TBL] [Abstract][Full Text] [Related]
12. Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.
Rusz J; Tykalová T; Klempíř J; Čmejla R; Růžička E
J Neural Transm (Vienna); 2016 Apr; 123(4):379-87. PubMed ID: 26843071
[TBL] [Abstract][Full Text] [Related]
13. [F0 characteristics in Parkinsonian speech: Contrast between the effect of hypodopaminergy due to Parkinson's disease and that of the therapeutic delivery of L-Dopa].
Ghio A; Robert D; Grigoli C; Mas M; Delooze C; Mercier C; Viallet F
Rev Laryngol Otol Rhinol (Bord); 2014; 135(2):63-70. PubMed ID: 26521344
[TBL] [Abstract][Full Text] [Related]
14. Levodopa effects on hand and speech movements in patients with Parkinson's disease: a FMRI study.
Maillet A; Krainik A; Debû B; Troprès I; Lagrange C; Thobois S; Pollak P; Pinto S
PLoS One; 2012; 7(10):e46541. PubMed ID: 23056337
[TBL] [Abstract][Full Text] [Related]
15. Acoustic analysis of parkinsonian speech II: L-Dopa related fluctuations and methodological issues.
Goberman AM; Coelho C
NeuroRehabilitation; 2002; 17(3):247-54. PubMed ID: 12237506
[TBL] [Abstract][Full Text] [Related]
16. Dilemma in the treatment of Parkinson's disease with L-dopa.
Kuno S
Eur Neurol; 1994; 34 Suppl 3():17-9. PubMed ID: 7821330
[TBL] [Abstract][Full Text] [Related]
17. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
Lees AJ; Tolosa E; Olanow CW
Mov Disord; 2015 Jan; 30(1):19-36. PubMed ID: 25488030
[TBL] [Abstract][Full Text] [Related]
18. Impact of levodopa treatment in the voice pattern of Parkinson's disease patients: a systematic review and meta-analysis.
Pinho P; Monteiro L; Soares MFP; Tourinho L; Melo A; Nóbrega AC
Codas; 2018 Oct; 30(5):e20170200. PubMed ID: 30304100
[TBL] [Abstract][Full Text] [Related]
19. EEG power spectral changes secondary to L-DOPA treatment in parkinsonian patients: a pilot study.
Yaar I
Electroencephalogr Clin Neurophysiol; 1977 Jul; 43(1):111-8. PubMed ID: 68867
[TBL] [Abstract][Full Text] [Related]
20. [The L-dopa test in Parkinson's disease].
Esteguy M; Bonnet AM; Kefalos J; Lhermitte F; Agid Y
Rev Neurol (Paris); 1985; 141(5):413-5. PubMed ID: 4048732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
